SCHEMBL4746435

SCHEMBL4746435

Oc1cccc2c1NC(Nc1ccccc1Cl)=NS2

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 14/20 0.56
CXCR1 P25024 5/20 0.46
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ATM Q13315 1/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TTR P02766 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4648961 0.85 CXCR2 (0.58) CXCR2CXCR1CYP2C9KMT2AMEN1
SCHEMBL18953433 0.81 CXCR2 (0.40) CXCR2KMT2AMEN1KDM4EMAPT
SCHEMBL4648882 0.78 CXCR2 (0.64) CXCR2CXCR1CYP2C9KMT2AMEN1
SCHEMBL5955072 0.78 CXCR2 (0.47) CXCR2CXCR1CYP2C9
SCHEMBL18953514 0.77 CXCR2 (0.46) CXCR2CXCR1CYP2C9KMT2AKDM4E
SCHEMBL18953337 0.74 CXCR2 (0.44) CXCR2CXCR1CYP2C9KMT2AKDM4E
SCHEMBL18953524 0.74 CXCR2 (0.44) CXCR2CXCR1CYP2C9KMT2AKDM4E
SCHEMBL18953362 0.73 CXCR2 (0.43) CXCR2CXCR1KMT2AMEN1KDM4E
SCHEMBL18953469 0.73 CXCR2 (0.59) CXCR2CXCR1CYP2C9
SCHEMBL18953471 0.73 CXCR2 (0.59) CXCR2CXCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631559-A4 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2008-08-27 EP disclosed
EP-1631559-A2 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2006-03-08 EP disclosed
WO-2005000231-A2 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2005-01-06 WO disclosed